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Abstract
Introduction: Even in countries with universal healthcare systems, excess mortality rates due to physical chronic
diseases in patients also suffering from serious mental illness like schizophrenia is such that their life expectancy
could be lessened by up to 20 years. The possible explanations for this disparity include: unhealthy habits (i.e.
smoking; lack of exercise); side-effects of psychotropic medication; delays in the detection or initial presentation
leading to a more advanced disease at diagnosis; and inequity of access to services. The main objective of this
paper is to explore the feasibility and acceptability of patient partnership for developing an interactive guide to
improve access to primary care providers for chronic diseases management and health promotion among patients
with severe mental illnesses.
Methods: A participatory action research design was used to engage patients with mental illness as full research
partners for a strategy for patient-oriented research in primary care for persons with schizophrenia who also have
chronic physical illnesses. This strategy was also developed in partnership with a health and social services centre
responsible for the health of the population of a territory with about 100,000 inhabitants in East-end Montreal,
Canada. A new interactive guide was developed by patient research partners and used by 146 participating
patients with serious mental illness who live on this territory, for them to be better prepared for their medical
appointment with a General Practitioner by becoming more aware of their own physical condition.
Results: Patient research partners produced a series of 33 short videos depicting signs and symptoms of common
chronic diseases and risk factors for the leading causes of mortality and study participants were able to complete
the corresponding 33-item questionnaire on an electronic touch screen tablet. What proved to be most relevant in
terms of interactivity was the dynamic that has developed among the study participants during the small group
learning sessions, a training technique designed for healthcare professionals that was adapted for this project for,
and with patient partners.
Conclusion: This research has shown the feasibility and acceptability of patient partnership and patient-oriented
research approaches to the R&D process of a new medical tool and intervention for patients with serious mental
illness, and its acceptability for addressing inequity of this disadvantaged population in terms of access to primary
care providers.
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Introduction
Chronic diseases are the leading causes of death in
Canada with more than 75 % of deaths attributable to
one of the following disorders: cancer, cardiovascular
disease, diabetes, kidney disease and respiratory disease.
While the causes of chronic illnesses are not fully
known, research has identified a range of apparently
interrelated personal, social, economic, and environ-
mental factors associated with the onset of those ill-
nesses. Mortality from physical illnesses is over 70 %
higher in psychiatric patients in relation to that of the
general population, even after adjusting for demograph-
ics, including socio-economic status. Thus, people with
schizophrenia have a substantially raised risk of prema-
ture death, and of great concern is that this risk might
be increasing, rather than decreasing [1]. Although
many factors are likely to contribute to the poor health of
this population, explanations usually point to lifestyle
factors (e.g. lack of exercise, alcohol and tobacco use).
However, mortality remains high for this population even
after adjusting for behavioural risk factors such as smok-
ing, physical activity and body mass index. Patients with
mental illness are more likely to delay seeking care, which
is likely a contributor to the increase in mortality among
these patients. It has also been shown that people with
mental illness have inequitably less access to primary care
providers, partly due to lack of thorough investigation
and poor communication skills [2, 3].
All mental disorders are associated with increased
risk of premature death [4]. Excess mortality rates due
to physical chronic diseases in patients also suffering
from serious mental illness like schizophrenia are such
that their life expectancy could be lessened by up to
20 years [5–7]. The possible explanations for this dis-
parity include: unhealthy habits (e.g. smoking, lack of
exercise), side-effects of psychotropic medication; de-
lays in the detection or initial presentation leading to a
more advanced disease at diagnosis, and iniquity in the
access to services in terms of care trajectories [8]. In
effect, despite showing no greater incidence of chronic
diseases, people with a mental illness, especially severe
mental illness (SMI: schizophrenia, schizotypal disorder
and delusional disorder, as defined in Chapter 5 of the
International Classification of Diseases) are clearly less
likely to receive or to adhere to adequate treatment [9];
this is in spite of consultation rates being generally high
among this population. The main causes of mortality in
patients with schizophrenia are the same as for the rest
of the population (cardiovascular diseases and cancer),
but individuals with SMI are prone to many different
physical health problems. And while these diseases are
also prevalent in the general population, their impact
on individuals with SMI is significantly increased [10].
Yet, there is a greater delay for vital medical and
surgical interventions for these patients compared to
the general population [11].
To address this important public health problem, we
are currently implementing a strategy of patient-
oriented research for people with schizophrenia who
are attending primary care for treatment of comorbid
physical illness in the East-end of Montreal, Canada.
Among the objectives is the development of a new
Interactive Guide for Medical Appointments (IGMA).
This paper reports on the contribution of people with
mental illness to the research and development process
(R&D) of the IGMA. We are particularly interested in
the concept of diagnostic overshadowing; the over
attribution of symptoms to any underlying or chronic
condition, resulting in missed diagnoses and the im-
proper management of conditions [2]. This is especially
problematic in people with mental illness because they
have higher rates of morbidity and shorter lifespans
than the general population and evidence shows that
enhancement of primary care services for such disad-
vantaged populations is essential to reducing health
and health care inequities [12].
Materials and methods
This study was reviewed and approved by the Institutional
Review Board of Institut universitaire en santé mentale de
Montréal, in the Canadian province of Quebec. It is being
piloted by mental health service users who interact with
study participants in small group learning sessions to
document their perception of their own physical condi-
tion through the use of the IGMA. The IGMA displays
self-administered questions targeting the signs and
symptoms of common chronic diseases and risk factors
for the leading causes of mortality. It was developed to
assist in the diagnosis of physical illnesses in people
with SMI because SMI can impede the ability of med-
ical professionals to diagnose and address ongoing
physical illnesses. The IGMA survey can therefore be
used by medical professionals to ensure timely diagno-
sis of physical issues among patients with mental ill-
nesses, and can also be used by patients to become
more aware of their own physical condition and to feel
more comfortable in engaging themselves in health
promotion activities. It can also provide social support
when used and discussed in small groups.
Small group learning is an educational approach that
allows participants to develop problem solving, inter-
personal, presentational and communication skills that
are difficult to develop in isolation, and require feed-
back and interaction with other individuals. The goals
of small group learning include the following: 1) to
reinforce knowledge through problem solving; 2)
plumb the depths of a problem; 3) test assumptions; 4)
generate hypotheses and practice critical reasoning; 5)
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collaborate with peers, and; 6) to receive feedback. This
approach has been shown to be particularly effective
for improving doctor-patient communication [13]. For
this study we presume that, on the other way around, it
can also improve patient-doctor communication.
Difficult communication, social distance and the over-
all poor quality of interactions between health care pro-
viders and persons with a lower socioeconomic status,
which is the case with most patients with SMI, have
been identified as a barrier to healthcare for disadvan-
taged populations in Quebec [14] and elsewhere [15].
Therefore, the IGMA has been developed to facilitate
this patient-doctor communication through a participa-
tory action research type of equitable participation that
allows non-academic members of the co-research team
to immediately benefit from the research findings and to
become directly involved in the knowledge translation
process [10, 16].
Participatory development process and governance
Participatory action research (PAR) is an approach that
involves study participants in all aspects of the process,
from conceptualization to data collection, through
interpretation and dissemination of findings. Involving
study participants as partners is a fundamental tenant
of the PAR approach [17]. Co-learning, building on
strengths and acknowledgement of privilege and power
are additional characteristics. This project is participa-
tory in many ways, and based on the field notes and on
researchers’ reflective notes, this paper reports on the
contribution of patient research partners in the R&D of
the IGMA as it relates to access and equity.
The research team followed as strictly as possible the
development process that was implemented in Australia
by the Queensland Government with the Activate: Mind
& Body project [18]. At the time of the study, very
significant structural reforms were underway in Quebec.
With the enactment of Law 10 the Quebec government
tabled major overhaul of the health and social services
network in order to modify its organization and govern-
ance, in particular by abolishing the regional agencies
and reducing the number of administrative levels, the
number of officers and boards of directors. As of April
1st 2015, the province’s 18 health and social services
regional agencies and 182 health institutions have been
amalgamated into just 28 institutions for the stated pur-
pose of optimizing network efficiency. To ensure project
acceptability in the eyes of practitioners in the field, it
was important to underline its bottom-up rather than
top-down nature. The patient partner expertise has been
put at the forefront as a branding for the project, so that
this project is an example of a patient-centered and even
patient-led approach rather than centered on institu-
tions’ needs. Thus, this project aimed to decisively
improve the physical and oral health outcomes of those
Australians with SMI by working collaboratively with
public mental health services, primary health care pro-
fessionals and non-government organisations to provide
support and education to consumers of mental health
services and their carers. With the IGMA project,
patients are also actively involved in such a process as
research partners throughout (patient research part-
ners). For instance, this project was coordinated by pa-
tients who are members of the International Program
for Participatory-Action Research (IPPAR), a non-profit
organisation which is based at Institut universitaire en
santé mentale de Montréal (IUSMM: Montreal Mental
Health University Institute). The IPPAR is a consumer-
and carer-run agency that specializes in participatory
research for citizenship-oriented mental health policies
and systems transformation [19]. The IPPAR is also a 5
year research program funded by the Canadian Institutes
of Health Research (knowledge translation priority an-
nouncement) and the Fonds de la recherche du Québec –
Santé. The mission of the IPPAR is twofold:
– to translate the experiential knowledge of consumers
and carers into scientific evidence;
– to experiment the research and scientific milieu as
an inclusive workplace for them.
The development of the IGMA has been a collabora-
tive initiative based on expert knowledge and practice
with multiple resources and stakeholders, and patients
were involved in the R&D process from inception on.
First, 2 patients were members of an Advisory Board
that provided leadership and advice to the Co-Research
Team for the adaptation of the Australian Activate Mind
and Body guidelines to Montreal. The Advisory Board
and Co-Research Team consisted of expert practitioners
from a range of fields, with some of them being involved
in both, while the IPPAR was solely comprised of service
users and carers (Table 1).
Close collaboration and consultation between the
Advisory Board and Co-Research Team was undertaken
at all key stages of development, with each draft of the
IGMA taking account of their input and feedback. The
IGMA was therefore developed and implemented
through a participatory process with a local health or-
ganisation that ensured key stakeholders were able to
review and provide comment on the final production
of the IGMA. Some members of the Advisory Board
were involved in the selection of the IGMA questions.
The Advisory Board is also very actively involved in the
planning of the small group learning schemes that are
offered to GPs through the continuous medical training
activities of the East-end Montreal local health author-
ity, for them to be informed about the concept of
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diagnostic overshadowing [2] and to discuss ways to
better integrate physical and mental health care in
primary care. Advisory Board members are also im-
portant conveyors of the ongoing knowledge transla-
tion strategies.
Study participants and nature of participation
SMI affects around 0.3–0.7 % of people at some point in
their life [20]. Therefore, for a population of 100,000
inhabitants, approximately 500 persons could be affected
by SMI at any time. The IUSMM Archives Department
provided a list of 467 patients with SMI who live one
the East-end Montreal sector covered by the local health
and social services centre, according to their postal
codes. From those who were contacted by phone by
research assistants who were using that list, 146 patients
agreed to participate and have completed the IGMA
between September 2014 and January 2015. This 31.3 %
participation rate is almost exactly what could have been
expected, according to Mojtabai et al. for a study on a
similar topic [21]. 95 of them were males (65.1 %) and
51 were females (34.9 %). Systematic reviews show that
it is more common in men than women with a risk ratio
of 1.4:1 [22]. The mean age is 52.7 years old with a
standard deviation of 14.8 years.
Study participants are expected to meet their GPs
(T2) to show them the results to the IGMA within 12
months after T1, and they receive a 50$ compensation
for each T1 and T2. In effect, one objective of the larger
study is to assess whether there will be a change in
terms of health promotion and follow up trajectories by
comparing the rates of avoidable admissions or proce-
dures to other psychiatric patients of the East-end
Montreal sector and to the general population of the
province of Quebec after T2. This paper reports the
results at T1, as collected with the IGMA that was used
by study participants who were met in small groups of
up to 5 participants each. Approximately half of these
small groups were held at the IPPAR-IUSMM and the
other half were held within specialized residential
resources for participants with lesser autonomy. The
patient research partners of the co-research team were
following a script for the conduct of these small group
learning meetings and they were assisting the study
participants in completing the IGMA questionnaire.
More than 95 % of study participants were using an
electronic tablet for the fist time.
The IGMA was developed through a series of itera-
tions and field notes were taken to observe and docu-
ment the participatory R&D process. A psychiatrist (one
of the investigators) and a GP (member of the Advisory
Board) were asked to independently select among 150
questions that were gathered by a patient who is also a
physician and research assistant, as per the above
Table 1. She used her experience and went back to clas-
sic textbooks of medical education [23, 24] for this wide
range of clinical issues and questions that it would
ideally be recommended to cover for a comprehensive
medical history of patients. From the 150 questions the
psychiatrist and the GP independently identified those
conditions that seemed to them to be the most import-
ant to be documented in an individual medical record of
any patient. They selected about 50 questions each, of
which 30 were common to both the psychiatrist and
the GP. After discussion with the Advisory Board, 3
more questions were added. The 33-item electronic
form produces an individualized profile of medical his-
tory which is printable on a single sheet to be shown by
the patient at the time of the medical appointment with
a GP. The items covered by the Australian Guidelines
Table 1 Composition of the Advisory Board, the Co-Research Team and the IPPAR
Expert Practitioners Advisory Board Co-Research Team IPPAR
Physician with mental illness* ✓ ✓ ✓
Psychiatrist* ✓ ✓
Director of the IPPAR* ✓ ✓ ✓
Investigator familiar with the Australian Guidelines* ✓
Adjunct director of the local health authority ✓ ✓
General Practitioner ✓ ✓
Practicing nurse ✓
Family member (mother of a person with SMI) ✓
Communication specialist with health professionals ✓
University professor of nursing ✓ ✓
Research assistants with mental illness ✓ ✓ ✓
PhD candidate in nursing ✓
*Authors of this paper
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are also covered by the IGMA and the 33 questions of
the IGMA can be answered on a binary scale (yes-no
questions) [25]. Yes-no questions are typically used by
medical staff when they ask patients to fill out ques-
tionnaires in waiting rooms.
For each of the IGMA questions, the patient research
partner with medical training prepared a description of
the covered symptom or sign. The 33 descriptions were
based on official medical literature and approved by the
abovementioned practicing GP who took part in the
R&D process of the IGMA. They were gathered in a 33
pages paper document with a selection of recom-
mended medical websites for the reader to learn more
about a particular condition and on how to possibly
prevent this condition with improved health literacy
and behavioural change. Two other mental health ser-
vice users and patient partners were asked to carefully
read these descriptions along with the questions. They
thus encapsulated 33 short videos with their lay lan-
guage, and their colleague with medical training was
there all the time to ensure that every important aspect
was appropriately covered. The IGMA was presented to
the Advisory Board members who approved the con-
tent and the approach, including the videos, and study
participants began to use the IGMA (T1). In a future it-
eration of the IGMA, we plan to provide additional aids
like graphs or other interactive aids to help the viewers
better understand the questions.
In the next phase of the study, we will measure out-
comes from the use of the tool by comparing hospital
separations including diagnoses and procedure codes,
and physician billings including diagnoses and proce-
dures. Results for the semi-experimental group of pa-
tients with SMI will be compared to that of the other
psychiatric patients of the East-end Montreal sector
(Control 1), the other SMI patients of Quebec (Control
2), and Quebec’s general population (Control 3). Data
sources are the administrative data of the Régie de
l’assurance maladie du Québec (RAMQ) for these 4
groups. Matched controls (Control 3) will be identified
within the RAMQ routine data sources as patients with-
out SMI, matched for physical co-morbidities in the
previous year, using the Charlson-Deyo comorbidity
index, a validated method of classifying comorbidity to
predict short and long-term mortality from medical
records [26, 27]. To add to the power of the study we
aim to identify at least five controls to every one case
[28], and matched controls will be identified within the
RAMQ as live individuals matched on age (to the near-
est year) and gender who were registered within the
RAMQ for the non-affective diagnoses codes at least
1 year prior to matched cases of the intervention group
for Controls 1 and 2, and for physical co-morbidities for
Control 3.
Results
Participants were offered coffee and muffins, and then
viewed each video before answering the corresponding
specific question on the touch screen of an electronic
tablet. On average, it took 90 min for participants to
view all the 33 videos and complete the questionnaire.
After completion, they were given the paper document,
including their individual answers listed on a single sheet
that resembles Table 2, which presents the results in
percentages of participants who answered “yes” to the
IGMA questionnaire at T1 (n = 146 patients who all
participated in small group sessions).
Thus, with regards to participating patients, data col-
lection has been completed for T1. All participating
patients effectively viewed the videos and successfully
completed the questionnaire. They left the small group
learning sessions with a paper copy of the IGMA and
questionnaire results for sharing with their GPs (73
have already done so as of May 31st 2015). Field notes
indicate that these small group learning schemes repre-
sent an acceptable means of gathering patients with
SMI for them to discuss and be more aware of their
own physical health condition. Among the limitations,
though, is that we cannot yet conclude to the effective-
ness of the tool in terms of care pathways and health
outcomes for study participants compared to other psy-
chiatric patients of the East-end Montreal territory, nor
to the general population of the province of Quebec
because their GPs have not yet been met. The Direction
of Family Medicine of the East-end Montreal local
health authority has agreed to facilitate and coordinate
the participation of the GPs, for them to be met, too, in
small group learning sessions to discuss ways to better
integrate physical and mental health care in primary
care. Other potential barriers to effective implementa-
tion are the perceptions of incompetence, of danger-
ousness, and of permanent impairment that health care
providers, like the public in general, can have towards
patients with SMI [29]. The active and visible participa-
tion of patients in the small group sessions among
health care providers should help to generate a more
positive image and to strengthen GP’s confidence in
engaging themselves in health promotion dialogue with
SMI patients.
To improve their health literacy, participating pa-
tients were exposed to the 33 videos and each time they
were suggested reliable medical websites for further
exploration in the paper document with which they
were leaving the small group sessions. Their perception
of their own physical condition was documented by
answering the 33 questions. They were given their own
individual results (the last page of the IGMA paper
document to be shown to the health care provider) and
Table 2 presents the aggregated results (n = 146).
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These results can be combined in multiple ways and
be cumulative in their effects. Some patients can have
multiple chronic diseases, which are more or less in-
capacitating. For others, a single one can have as much
consequences as a combination of several “milder” con-
ditions. Combinations can vary in terms of number
and/or intensity, and nature of the diseases. Emphy-
sema and asthma are reported by about 18 % of partici-
pants, so many frequently feel out of breath (27 %).
About 36 % have abnormal movements or tremor,
which may be side effects of psychotropic medication.
Each of the single results would deserve a detailed ana-
lysis, for example in comparing the 35.9 % prevalence
of diabetes among study participants to 8.3 % for the
population of Quebec [30].
The results could also be presented in combination.
An example of complex combination, for instance, is
morbidity due to oral disease. As shown in Table 2, not
even half of study participants self-reported that they do
brush their teeth. More than 55 % still smoke (56.3 %).
These are changeable lifestyle habits. Better management
of oral health is possible through the treatment of oral
Table 2 Results to the Interactive Guide for Medical Appointments (IGMA) at T1 (n = 146)
# Question Yes
1 Have you ever been treated for a heart disease? 17.6 %
2 Have you ever been treated for high blood pressure? 28.9 %
3 Have you ever been treated for diabetes? 35.9 %
4 Have you ever been treated for chronic bronchitis or emphysema? 17.6 %
5 Have you ever been treated for asthma? 18.3 %
6 Have you ever been treated for cancer? 11.3 %
7 Have you ever been treated for thyroid malfunction? 14.8 %
8 Have you ever been treated for chronic pain? 23.9 %
9 Has one of your relatives been victim of a cerebrovascular accident (stroke), of a heart disease or of cancer? 62.7 %
10 Do you suffer from allergies? 34.5 %
11 Have you consulted with the emergency or walk-in clinic during the past year? 35.9 %
12 Have you lost weight unintentionally over the last 6 to 12 months? 14.8 %
13 Do you have pain that wakes you up at night? 20.4 %
14 Do you have frequent or severe headaches limiting your activities? 18.3 %
15 Have you fainted recently? 3.5 %
16 Do you have any abnormal movements or tremors? 35.9 %
17 Do you frequently feel out of breath? 26.8 %
18 You spit blood when coughing? 0.7 %
19 Have you ever had blood in your stool or black stools? 13.4 %
20 Have you noticed blood in your urine? 3.5 %
21 Have you noticed an increase in the frequency with which you urinate or an increased volume of your urine? 26.1 %
22 Do you have any unusual discharge from the vagina or the penis? 4.9 %
23 Have you noticed a change in the appearance of your moles? 5.6 %
24 Have you ever been tested for colon cancer over the past 2 years? (50 to 74 years old) 13.4 %
25 Have you had a gynaecological examination including a screening test for cervical cancer (PAP test) in the last 3 years? 37.3 %*
26 Have you had a mammogram screening for breast cancer (women aged 50 to 69) in the last 2 years? 33.4 %*
27 Have you been screened for sexually or blood transmitted infections? 12.0 %
28 Do you smoke? 56.3 %
29 Have you ever thought you should cut down on your drinking or have you ever been criticized by people around you because of your
drinking?
4.2 %
30 Do you use drugs (marijuana, heroin, cocaine, LSD, ecstasy, crystal meth, etc.) or psychotropic substances without prescription such as stimulants
(e.g. Ritalin), painkillers (e.g. Fentanyl), sedatives (e.g. Valium), etc.
7.7 %
31 Do you do 2.5 h of physical activity of moderate to high intensity in a week? 23.2 %
32 Do you eat at least seven servings of fruits and vegetables per day? 20.4 %
33 Do you brush your teeth every day? 47.2 %
*Women only
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diseases and prevention but among the most common
somatic disturbances observed in SMI patients is their
poor oral health [31]. Prevention implies well-educated
hygiene, rational use of complementary devices, the
acquisition of manual dexterity and regular reactivation
of guidelines and recommendations. In effect, to limit
the development of dental plaque, brushing is an effect-
ive mechanical action that prevents gingivitis. The pre-
ventable deterioration of oral health and its impact on
vital functions, especially as it relates to nutrition, may
affect the overall health and metabolic conditions of in-
dividuals. Improved overall quality of oral health would
decrease the need for curative treatment, which are
often invasive (use of “conscious sedation” or general
anaesthesia).
Also to note is that these results are self-reported,
they do not replace a medical report. It is thus very
much possible that those 47.2 % (brushing their teeth)
and 56.3 % (smoking) are embellished numbers due to
social desirability. Another social dimension and out-
come is that the oral cavity plays an important role in
the aesthetic appearance. Tooth loss symbolizes vital
physical decline with all its psychological consequences,
for example in terms of self-confidence in seeking and
maintaining healthier life habits, and in terms of com-
munication skills and presentation style. This is also
probably true with many other conditions. What the
next section discusses are not the numbers per se.
Rather, it is the participatory R&D process and use of
the IGMA as an interactive tool for data collection and
social interaction.
Discussion
In the Region of Montreal, when individuals are looking
for a family doctor in primary care, they need to fill out
an electronic form that is provided by the local health
authority on its website. The IGMA questionnaire
covers these basic questions, with the addition of a
number of questions that were based on 3 expert opin-
ions. Although these Montreal-based experts do have a
professional expertise about SMI patients’ particular
needs of supplemental assessment with regards to their
physical condition, this is a limitation compared to
systematic approaches like systematic literature reviews,
clinical guidelines, or expert consensus.
In recent years, mobile applications and such elec-
tronic forms have become part of daily life for many,
and they have also entered the medical field [32]. For
example, such applications can be used by patients who
would like to quit smoking [33], to lose weight [34], or
to assess anxiety [35]. Some populations, however,
remain significantly disadvantaged in terms of access to
such technologies, as is the case with the vast majority
of participants in this study who had never handled an
electronic tablet or completed an electronic form before
using the IGMA. They nevertheless were able to do so,
though with some support from the patient research
partners. As health institutions are more and more refer-
ring the population they deserve to their websites for
information and registration, they should be aware of
groups with lower Internet access when planning to
offer consumer health information technology. Respond-
ing to the needs of such socioeconomically disadvan-
taged groups is challenging for family physicians and
primary care teams [36, 37]. This is an important issue
in terms of equity of access for under deserved groups
who are at risk of being technologically left behind [38].
There were a number of challenges that required spe-
cial assistance during the process. For example, at
times, it was difficult for some participants to stay
focused on the task. The team of 2 peer research assis-
tants ensured that there was minimal distraction during
the small group sessions. Also, for some transportation
was an obstacle. In such circumstances, the team of
peer research assistants went in specialized housing
resources with five electronic tablets that were con-
nected to the internet. The leadership and input of
patient research partners of the IPPAR have been useful
in making the data collection procedure a positive,
empowering and genuinely personalized experience
that many of them might want to repeat in the future.
The fact that study participants were met by some of
their peers helped avoid inequalities in dialogue, as the
study participants’ full participation was not inhibited
by unequal power relationships [10]. Interactivity, here,
may be more about this equalitarian type of interaction
than about multimedia and touch screen technology.
The active participation of patients is a key compo-
nent of patient-centred research for stimulating the
translation of scientific and technological innovations
into benefits for patients [39]. The patient-centeredness
of this participatory research was characterised by an
enhanced level of patient commitment to this R&D
process of the IGMA and its use. Patient-centeredness
can contribute to better integration, continuity and flu-
idity among various stakeholder groups [40] and re-
search is increasingly demonstrating the usefulness of
including patients and considering their preferences in
health research [41, 42]. Innovation and investments in
patient centred research have become highly prioritized
in the United States [43], the United Kingdom [44] and
Europe [45], and Australia [46]. This project is part of
that trend, with clinicians and patients working in close
partnership to improve healthcare and challenge deeply
ingrained practices and behaviours [47]. Partnering
with patients, their families, carers, advocacy groups,
and the public is more and more seen as an ethical
imperative that is essential to improving the quality,
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safety, cost effectiveness, and sustainability of health-
care. Especially in the field of mental health, the practice
of patient partnership can be seen as the culmination of
decades of claims from advocacy groups demanding
equality, equity, and full citizenship for all [48].
Still often, new mobile applications are designed to
be used by professionals [49], and with a predominately
individual-based approach [50]. However, “individual-
ized” is not synonymous with “personalized”. A system
that is accessible is made up of health professionals
who are accessible, but beyond opening hours, patients
from lower social classes are often disadvantaged be-
cause of the doctor’s misperception of their desire and
need for information and their ability to take part in
the care process [11]. A tool like the IGMA can help
patients to better communicate with the GPs [51].
This study illustrates the relevance of participatory
action research in addressing an important public
health topic. People with mental illness and family
members were included in several ways. One was a co-
investigator, 2 others formed part of the Advisory Board
and 2 more were employed as peer research assistants.
Then, a young woman and a young man with SMI
made the videos, for a total of 7. Work in the mental
health field is attractive to many consumers, as it can
offer consumers the chance to socialize and help their
peers [52]. Hiring patient research partners who other-
wise would be unemployed [53] is yet another relevant
way to tackle inequity.
In their systematic review to assess the interformat
reliability of self-report symptom scales used in digital
or paper format, Alfonsson, Maathz and Hursti [54]
have concluded that when digital versions of self-report
symptom scales are compared to pen and paper ver-
sions, most scales show high interformat reliability. For
our study, participating patients were offered to
complete the IGMA in its electronic or traditional
paper format interchangeably. The focus was on the
dynamic that took place among participants, with some
of them completing the electronic questionnaire and
only very few of them preferred to complete the paper-
pen questionnaire. In either way, they all had to view
the short videos before answering each question and
one of the reasons why the overall process lasted up to
90 min was that participants tended to discuss among
themselves in order to exchange some tips, for example,
as how to better control this or that particular condi-
tion. In effect, each time the content of the videos was
describing a common medical condition in a lay lan-
guage for participants to be able to eventually recognize
it. Participants were explained that the narrators in the
videos were also people living with SMI and this infor-
mation probably gave them confidence in engaging
themselves, too, in the discussion. Finally, through this
study, participating patients have experienced informa-
tion and communication technologies by filling out an
electronic questionnaire, a premiere for several of them.
As explained in the IGMA that is shown to the health
care providers, their answers to these 33 questions do
not replace a medical diagnosis or record. Nevertheless,
so far the use of the IGMA has been shown to be useful
in raising awareness about the diagnostic overshadow-
ing phenomenon because health care providers can see,
so to say “at a glance”, that some of their SMI patients
have a long history of combined physical conditions.
Conclusion
The main objective of this paper was to explore and
confirm the feasibility and acceptability of patient part-
nership for developing an interactive guide to improve
access to primary care providers for chronic diseases
management and health promotion among patients with
severe mental illnesses. Difficult communication and so-
cial distance have been identified in the literature as bar-
riers to equitable access to primary care providers and
this access can be improved through the use of a tool
like the IGMA and the interactivity and collective social
support that its use generates among small groups of
patients.
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